AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
ENALAPRIL MALEATE in Malawi
18 products registered with PMRA — 0 active, 18 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ZENAPRIL 10MG TABLET TABLET | PMPB/PL347/5 | — | expired | 31 Mar 2025 |
| ENA_DENK_10 10MG TABLET TABLET | PMPB/PL129/56 | — | expired | 31 Mar 2025 |
| DAWAPRIL_10 10MG TABLET TABLET | PMPB/PL12/127 | — | expired | 31 Mar 2025 |
| ENLOW-5 5MG TABLET TABLET | PMPB/359/24 | — | expired | 31 Mar 2024 |
| ENLOW-10 10MG TABLET TABLET | PMPB/359/23 | — | expired | 31 Mar 2024 |
| ENALAPRIL 5MG TABLET TABLET | PMPB/PL252/11 | — | expired | 31 Mar 2024 |
| PRILOTEN_10 10MG TABLET TABLET | PMPB/PL373/35 | — | expired | 31 Mar 2023 |
| AMPRIL_10 10MG UNCOATED TABLET UNCOATED TABLET | PMPB/PL514/4 | — | expired | 31 Mar 2023 |
| ENVAS_10 10MG TABLET TABLET | PMPB/PL26/35 | — | expired | 31 Mar 2022 |
| DAWAPRIL_5 5MG TABLET TABLET | PMPB/PL12/128 | — | expired | 31 Mar 2022 |
| AMPRIL_5 5MG UNCOATED TABLET UNCOATED TABLET | PMPB/PL514/5 | — | expired | 30 Jun 2021 |
| ENA_DENK_20 20MG TABLET TABLET | PMPB/PL129/57 | — | expired | 30 Jun 2017 |
| ENALAPRIL 5MG TABLET TABLET | PMPB/PL160/28 | — | expired | 30 Jun 2015 |
| ENALAPRIL 10MG TABLET TABLET | PMPB/PL419/10 | — | expired | 30 Jun 2014 |
| ENTAB_5 5MG TABLET TABLET | PMPB/PL419/11 | — | expired | 30 Jun 2014 |
| INVORIL 5MG TABLET TABLET | PMPB/PL67/29 | — | expired | 30 Jun 2013 |
| DILVAS-10 10MG TABLET TABLET | PMPB/PL167/133 | — | expired | 30 Jun 2012 |
| ENAM 5MG TABLET TABLET | PMPB/PL138/5 | — | expired | 31 Jul 2003 |
ENALAPRIL MALEATE — PMRA Registration Details
PMRA (Malawi) has 18 registered products containing ENALAPRIL MALEATE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track ENALAPRIL MALEATE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.